1. Home
  2. CGEM vs OEC Comparison

CGEM vs OEC Comparison

Compare CGEM & OEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • OEC
  • Stock Information
  • Founded
  • CGEM 2016
  • OEC 1862
  • Country
  • CGEM United States
  • OEC Luxembourg
  • Employees
  • CGEM N/A
  • OEC N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • OEC Major Chemicals
  • Sector
  • CGEM Health Care
  • OEC Industrials
  • Exchange
  • CGEM Nasdaq
  • OEC Nasdaq
  • Market Cap
  • CGEM 730.2M
  • OEC 856.0M
  • IPO Year
  • CGEM 2021
  • OEC 2014
  • Fundamental
  • Price
  • CGEM $10.55
  • OEC $14.56
  • Analyst Decision
  • CGEM Strong Buy
  • OEC Buy
  • Analyst Count
  • CGEM 7
  • OEC 2
  • Target Price
  • CGEM $31.67
  • OEC $23.50
  • AVG Volume (30 Days)
  • CGEM 551.6K
  • OEC 399.5K
  • Earning Date
  • CGEM 03-13-2025
  • OEC 02-19-2025
  • Dividend Yield
  • CGEM N/A
  • OEC 0.58%
  • EPS Growth
  • CGEM N/A
  • OEC N/A
  • EPS
  • CGEM N/A
  • OEC 0.54
  • Revenue
  • CGEM N/A
  • OEC $1,911,500,000.00
  • Revenue This Year
  • CGEM N/A
  • OEC $0.90
  • Revenue Next Year
  • CGEM N/A
  • OEC $4.45
  • P/E Ratio
  • CGEM N/A
  • OEC $26.98
  • Revenue Growth
  • CGEM N/A
  • OEC 1.26
  • 52 Week Low
  • CGEM $9.50
  • OEC $14.07
  • 52 Week High
  • CGEM $30.19
  • OEC $26.05
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 38.45
  • OEC 38.16
  • Support Level
  • CGEM $10.14
  • OEC $14.42
  • Resistance Level
  • CGEM $11.31
  • OEC $15.24
  • Average True Range (ATR)
  • CGEM 0.64
  • OEC 0.51
  • MACD
  • CGEM 0.01
  • OEC 0.04
  • Stochastic Oscillator
  • CGEM 30.11
  • OEC 27.07

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, create differentiated ideas, identify the appropriate targets, and select the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications.

About OEC Orion S.A.

Orion SA is a manufacturer of carbon black products. Carbon black is a powdered form of carbon used to create the desired physical, electrical and optical qualities of various materials. The company's operating segments are Specialty Carbon Black and Rubber Carbon Black. It generates maximum revenue from the Rubber Carbon Black segment. Rubber Carbon Black segment is used in the reinforcement of rubber in tires and mechanical rubber goods. The Specialty Carbon Black segment is used as pigments and performance additives in coatings, polymers, printing, and special applications. Geographically, it derives a majority of its revenue from Germany.

Share on Social Networks: